OUTLOOK Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . OUTLOOK THERAPEUTICS INC
OTLK Stock  USD 2.23  0.04  1.83%   
OUTLOOK THERAPEUTICS financial statements provide useful quarterly and yearly information to potential OUTLOOK THERAPEUTICS INC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on OUTLOOK THERAPEUTICS financial statements helps investors assess OUTLOOK THERAPEUTICS's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting OUTLOOK THERAPEUTICS's valuation are summarized below:
Gross Profit
-34.2 M
Market Capitalization
55.5 M
Enterprise Value Revenue
26.101
Revenue
5.9 M
Earnings Share
(4.06)
There are currently one hundred twenty trending fundamental ratios for OUTLOOK THERAPEUTICS INC that can be evaluated and compared over time across competitors. We recommend to check out OUTLOOK THERAPEUTICS's recent fundamental drivers against the all of the trends between 2010 and 2025. Market Cap is expected to rise to about 91.1 M this year. Enterprise Value is expected to rise to about 97.1 M this year

OUTLOOK THERAPEUTICS Total Revenue

0.0

Check OUTLOOK THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OUTLOOK THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.8 K, Interest Expense of 3.8 T or Selling General Administrative of 36.2 T, as well as many indicators such as Price To Sales Ratio of 2.84, Dividend Yield of 12.5 K or Days Sales Outstanding of 190. OUTLOOK financial statements analysis is a perfect complement when working with OUTLOOK THERAPEUTICS Valuation or Volatility modules.
  
Check out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors.

OUTLOOK THERAPEUTICS Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets34.8 T33.1 T6 T
Slightly volatile
Short and Long Term Debt Total20.1 M34.2 M20 M
Pretty Stable
Other Current Liabilities51.4 T48.9 T8.9 T
Slightly volatile
Total Current Liabilities51.4 T48.9 T8.9 T
Slightly volatile
Other Liabilities48.9 K51.4 K6.1 M
Slightly volatile
Property Plant And Equipment Net331.6 B315.8 B57.6 B
Slightly volatile
Accounts Payable4.3 M7.2 M6.6 M
Slightly volatile
Cash10.9 M17.2 M10.3 M
Slightly volatile
Non Current Assets Total1.7 T1.6 T295.3 B
Slightly volatile
Non Currrent Assets Other1.4 T1.3 T237.6 B
Slightly volatile
Long Term Debt13.1 M12.5 M6.6 M
Slightly volatile
Cash And Short Term Investments18 T17.2 T3.1 T
Slightly volatile
Net Receivables85.5 K90 K1.3 M
Slightly volatile
Common Stock Total Equity1.9 M2 M10.9 M
Slightly volatile
Common Stock Shares Outstanding22.4 B21.3 B3.9 B
Slightly volatile
Liabilities And Stockholders Equity34.8 T33.1 T6 T
Slightly volatile
Non Current Liabilities Total71.7 T68.2 T12.5 T
Slightly volatile
Other Current Assets15.1 T14.4 T3 T
Slightly volatile
Total Liabilities123 T117.2 T21.4 T
Slightly volatile
Property Plant And Equipment Gross234.8 K247.2 K8.6 M
Slightly volatile
Short and Long Term Debt35.5 M33.9 M15.6 M
Slightly volatile
Preferred Stock Total Equity4 M4.3 M10 M
Slightly volatile
Total Current Assets33.1 T31.5 T5.8 T
Slightly volatile
Short Term Debt35.6 M33.9 M16.9 M
Slightly volatile
Common Stock204.4 K215.2 K10.6 M
Slightly volatile
Property Plant Equipment60.2 K63.3 K6.7 M
Slightly volatile
Long Term Debt Total6.4 M12.5 M7.3 M
Slightly volatile
Deferred Long Term Liabilities102.1 K107.5 K1.1 M
Slightly volatile
Capital Surpluse278.9 M477.7 M254.5 M
Slightly volatile
Capital Lease Obligations254.6 K268 K1.3 M
Pretty Stable
Non Current Liabilities Other52.5 K55.3 K972.9 K
Pretty Stable
Warrants9.5 M12.3 M8.5 M
Slightly volatile
Capital Stock204.4 K215.2 K3.6 M
Slightly volatile
Long Term Investments647.3 K623.9 K838.6 K
Slightly volatile
Short Term Investments11.9 T13.4 T14.6 T
Slightly volatile

OUTLOOK THERAPEUTICS Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization37.8 K39.8 K1.8 M
Pretty Stable
Interest Expense3.8 T3.6 T662.5 B
Slightly volatile
Selling General Administrative36.2 T34.4 T6.3 T
Slightly volatile
Other Operating Expenses47.6 M61.1 M41.2 M
Slightly volatile
Research Development50.4 T48 T8.8 T
Slightly volatile
Cost Of Revenue48.3 K50.8 K87.7 K
Pretty Stable
Total Operating Expenses86.6 T82.5 T15 T
Slightly volatile
Minority Interest1.7 M944.4 K1.6 M
Slightly volatile
Interest Income774.8 K815.5 K2 M
Slightly volatile
Selling And Marketing Expenses239.1 K251.7 K2 M
Slightly volatile
Preferred Stock And Other Adjustments142 K149.5 K1.3 M
Slightly volatile
Reconciled Depreciation97.3 K102.5 K1.7 M
Slightly volatile
Non Recurring451.1 K474.9 K6.6 M
Slightly volatile

OUTLOOK THERAPEUTICS Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6.5 T6.2 T1.1 T
Slightly volatile
Begin Period Cash Flow28.2 T26.9 T4.9 T
Slightly volatile
Dividends Paid148.2 B191.1 B114.3 B
Slightly volatile
Total Cash From Financing Activities72.8 T69.4 T12.7 T
Slightly volatile
End Period Cash Flow18 T17.2 T3.1 T
Slightly volatile
Change To Netincome9.1 M11.5 M7.4 M
Slightly volatile
Change Receivables16 K18 K19.6 K
Slightly volatile
Issuance Of Capital Stock49.8 M69.4 M43.2 M
Slightly volatile
Other Cashflows From Investing Activities720 K810 K883.1 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.842.999.0102
Pretty Stable
Dividend Yield12.5 K11.9 K7.5 K
Slightly volatile
Days Sales Outstanding190271260
Slightly volatile
Average Payables2.5 M2.6 M5.2 M
Slightly volatile
Stock Based Compensation To Revenue0.180.190.7687
Slightly volatile
EV To Sales3.573.7610.7253
Pretty Stable
Payables Turnover0.00570.0060.0292
Pretty Stable
Sales General And Administrative To Revenue0.981.041.9166
Pretty Stable
Research And Ddevelopement To Revenue6.453.364.0169
Very volatile
Capex To Revenue0.05860.06170.2826
Slightly volatile
Cash Per Share761724174
Slightly volatile
Days Payables Outstanding88.3 K62.5 K119 K
Slightly volatile
Income Quality0.610.820.7103
Slightly volatile
Current Ratio0.640.580.7008
Slightly volatile
Receivables Turnover1.831.41.4866
Slightly volatile
Graham Number17.9 K17.1 K3.9 K
Slightly volatile
Average Receivables1.7 M1.9 M2.1 M
Slightly volatile
Revenue Per Share9.7810.337.2115
Slightly volatile
Interest Debt Per Share206196132
Slightly volatile
Debt To Assets0.00.00.5864
Slightly volatile
Operating Cycle190270260
Slightly volatile
Days Of Payables Outstanding88.3 K62.5 K119 K
Slightly volatile
Ebt Per Ebit1.191.211.0931
Slightly volatile
Quick Ratio0.640.580.7008
Slightly volatile
Net Income Per E B T1.121.151.0362
Pretty Stable
Days Of Sales Outstanding190271260
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.221.151.1362
Slightly volatile
Fixed Asset Turnover2.422.311.4618
Slightly volatile
Debt Ratio0.00.00.5864
Slightly volatile
Price Sales Ratio2.842.999.0102
Pretty Stable
Asset Turnover0.220.430.3397
Slightly volatile
Gross Profit Margin0.790.90.9772
Slightly volatile

OUTLOOK THERAPEUTICS Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap91.1 M49.8 M89.7 M
Pretty Stable
Enterprise Value97.1 M60.7 M99.1 M
Pretty Stable

OUTLOOK Fundamental Market Drivers

Forward Price Earnings2.8498
Cash And Short Term Investments14.9 T

OUTLOOK Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About OUTLOOK THERAPEUTICS Financial Statements

OUTLOOK THERAPEUTICS investors utilize fundamental indicators, such as revenue or net income, to predict how OUTLOOK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-27.8 K-26.4 K
Cost Of Revenue50.8 K48.3 K
Stock Based Compensation To Revenue 0.19  0.18 
Sales General And Administrative To Revenue 1.04  0.98 
Research And Ddevelopement To Revenue 3.36  6.45 
Capex To Revenue 0.06  0.06 
Revenue Per Share 10.30  9.78 
Ebit Per Revenue(5.12)(5.38)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether OUTLOOK THERAPEUTICS INC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if OUTLOOK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Outlook Therapeutics Inc Stock. Highlighted below are key reports to facilitate an investment decision about Outlook Therapeutics Inc Stock:
How To Invest In OUTLOOK
Details
Is OUTLOOK Stock a good investment?
Details
What is OUTLOOK THERAPEUTICS's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.06)
Revenue Per Share
0.119
Quarterly Revenue Growth
6.583
Return On Assets
(0.84)
Return On Equity
(0.04)
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY